Legal & General Group
AKYA

Legal & General Group’s Akoya BioSciences AKYA Stock Holding History

Legal & General Group’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,510
Closed -$3.49K – 3422
2025
Q1 		$3.49K Hold
2,510
– – ﹤0.01% 3321
2024
Q4 		$5.75K Hold
2,510
– – ﹤0.01% 3328
2024
Q3 		$6.82K Hold
2,510
– – ﹤0.01% 3340
2024
Q2 		$5.87K Hold
2,510
– – ﹤0.01% 3365
2024
Q1 		$11.8K Sell
2,510
-204
-8% -$1.06K ﹤0.01% 3170
2023
Q4 		$13.2K Buy
2,714
+469
+21% +$1.95K ﹤0.01% 3176
2023
Q3 		$10.4K Buy
2,245
+235
+12% +$1.35K ﹤0.01% 3257
2023
Q2 		$14.9K Hold
2,010
– – ﹤0.01% 3229
2023
Q1 		$16.4K Hold
2,010
– – ﹤0.01% 3121
2022
Q4 		$19.2K Sell
2,010
-99
-5% -$1.22K ﹤0.01% 3167
2022
Q3 		$24K Buy
2,109
+381
+22% +$5.02K ﹤0.01% 3156
2022
Q2 		$22K Sell
1,728
-194,341
-99% -$2.01M ﹤0.01% 3195
2022
Q1 		$2.15M Sell
196,069
-6,799
-3% -$78.8K ﹤0.01% 1950
2021
Q4 		$3.11M Buy
202,868
+25,447
+14% +$333K ﹤0.01% 1829
2021
Q3 		$2.48M Buy
177,421
+176,619
+22,022% +$2.95M ﹤0.01% 1922
2021
Q2 		$16K Buy
+802
New +$16.6K ﹤0.01% 3357

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Legal & General Group's AKYA Position: Q2 2025 in Review

Legal & General Group sold out of Akoya BioSciences (AKYA) in Q2 2025, closing a stake of 2,510 shares — an estimated $3.49K sold.

Legal & General Group first reported a position in AKYA in Q2 2021 and held it in 16 quarters. The position peaked at $3.11M in Q4 2021. 58 funds tracked by Wall St. Rank hold AKYA as of Q2 2025.

  • Legal & General Group reported no remaining Akoya BioSciences position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 2,510 Akoya BioSciences shares in Q2 2025, an estimated $3.49K.
  • Legal & General Group first reported a position in Akoya BioSciences in Q2 2021 and held it in 16 quarters.
  • Legal & General Group's Akoya BioSciences position peaked at $3.11M in Q4 2021.
  • 58 funds tracked by Wall St. Rank held Akoya BioSciences as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.